Periodontal Disease, AVDC Stage 3
5
0
1
3
Key Insights
Highlights
Success Rate
100% trial completion (above average)
Treatment Research
9 treatments under study, led by Emdogain Enamel Matrix Derivative
Research Leaders
10 sponsors active, led by Universitat Internacional de Catalunya
Related Conditions
Often studied with 8 related conditions
Clinical Risk Assessment
Based on trial outcomes
Moderate Risk
Score: 40/100
0.0%
0 terminated out of 5 trials
100.0%
+13.4% vs benchmark
20%
1 trials in Phase 3/4
0%
0 of 3 completed with results
Key Signals
Data Visualizations
Phase Distribution
Trial Status
Trial Success Rate
Benchmark: 86.6%
Based on 3 completed trials
Clinical Trials (5)
ABX Versus CHX in NSPT
Fasting-mimicking Diet and Periodontitis (FMD)
Melatonin Gel as an Adjuvant in the Surgical Management of Intrabony Defects
Flapless Application of Enamel Matrix Derivative in Class II Mandibular Furcation Defects
Low-level Laser Therapy as an Adjunct to Non-surgical Periodontal Treatment
Research Network
Common Treatments
- Emdogain Enamel Matrix Derivative1
- Melatonin Gel Mixed With Xenograft1
- Emdogain Fl Flapless Emdogain Enamel Matrix Derivative1
- Fastingmimicking Diet Nonsurgical Periodontal Therapy1
- Chx As Adjunctive To Non Surgical Periodontal Treatment1
Active Sponsors
- Universitat Internacional de Catalunya1
- King's College London1
- Aristotle University Of Thessaloniki1
- University of Roma La Sapienza1
- Universidad Complutense de Madrid1
Top Investigators
King's College London
Beykent University
Related Conditions
- Periodontal Disease Avdc Stage 43
- Periodontal Diseases2
- Periodontal Disease1
- Periodontal Attachment Loss1
- Periodontal Inflammation1